Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Preclinical biomarker research and patient stratification of molecular target agents: the anti-angiogenic inhibitor Lenvatinib mesylate (E7080)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 1 Oct 2013

Matsui Junji, Funahashi Yasuhiro

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Drug Evaluation, Preclinical
Share to Molecular Targeted Therapy
Share to Phenylurea Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to PTEN Phosphohydrolase

Share to Quinolines

Share to Receptors, Vascular Endothelial Growth Factor

Share to Translational Research, Biomedical

Source

Identifiers

PMID: 24107519
DOI: 10.1254/fpj.142.162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

[Preclinical biomarker research and patient stratification of molecular target agents: the anti-angiogenic inhibitor Lenvatinib mesylate (E7080)].PMID 24107519Read ↗

[Gene mutation (KRAS, BRAF, PIK3CA) and clinical benefit of anti-EGFR antibody].Semantic proximity Read ↗

CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?Semantic proximity Read ↗

[Selective tyrosine kinase inhibitor imatinib (STI571) in haematological and oncological disease].Semantic proximity Read ↗

MiRNA-181d Expression Correlates in Tumor versus Plasma of Glioblastoma Patients—the Base of a Preoperative Stratification Tool for Local Carmustine Wafer UseSemantic proximity Read ↗

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.Semantic proximity Read ↗

Predicting benefit from imatinib: are we close?Semantic proximity Read ↗

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.Semantic proximity Read ↗

Strategies to design clinical studies to identify predictive biomarkers in cancer research.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.